Início › Mieloma Múltiplo Indolente › Nova York

Ensaios clínicos de Mieloma Múltiplo Indolente em Nova York

8 estudos para Mieloma Múltiplo Indolente estão buscando participantes em locais em Nova York.

Cidades em Nova York

New York City6 estudos

Texto oficial do estudo (Inglês)

A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07393282

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Hematology Oncology Associates of CNY at Camillus, Camillus
Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse
Mount Sinai Chelsea, New York
e mais 2

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT03937635

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

NYU Langone Health Perlmutter Cancer Center, New York
Stony Brook University Hospital, Stony Brook

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 8 de jul. de 2026 · NCT06140524

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
e mais 1

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 16 de abr. de 2026 · NCT05640843

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Roswell Park Cancer Institute, Buffalo

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 1 de dez. de 2025 · NCT05312255

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
e mais 1

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 13 de nov. de 2025 · NCT06055894

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York

RecrutandoEstudo observacional

Idades 40 e acima · Todos os sexos · Atualizado em 6 de ago. de 2025 · NCT06365060

Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma

University of Rochester, Rochester

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 10 de fev. de 2025 · NCT05597345

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.